Texas Oncology-Abilene

Abilene, Texas 79606-5208

1 studies enrolling now · 10 studies all time

What they study most

Advanced Prostate Cancer, Breast Cancer, Chronic Lymphocytic Leukemia (CLL), Locally Recurrent Breast Cancer, Metastatic Breast Cancer, Non Small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Ovarian Cancer, Prostatic Neoplasms

Studies at this site

• Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
• Breast Cancer Index (BCI) Registry — Running, not enrolling
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• informCLL™: A Disease Registry for Patients With Chronic Lymphocytic Leukemia — Completed
• The BEACON Study (Breast Cancer Outcomes With NKTR-102) — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — Completed
• Ixabepilone + Carboplatin Metastatic Breast Cancer — Completed
• Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer — Completed